HOWARD H PIEN Insider Trading $JUNO Juno Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HOWARD H PIEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HOWARD H PIEN. HOWARD H PIEN is Chairman & CEO in CHIRON CORP ($CHIR) and President & CEO in CHIRON CORP ($CHIR) and Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in Juno Therapeutics, Inc. ($JUNO) and in Sage Therapeutics, Inc. ($SAGE).
HOWARD H PIEN in Juno Therapeutics, Inc.
Trading Symbol: JUNOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of HOWARD H PIEN: Director
Holdings: 117,799 shares
Current Value: $2,445,507
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of HOWARD H PIEN in Juno Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CHIR, IDRA, IMGN, JUNO, SAGE, VNDA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | D | 42.40 | 12,000 | 508,800 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | D | 60.00 | 12,000 | 720,000 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Sell | D | 87.00 | 5,050 | 439,350 | 0 | 5.1 K to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Sell | U | 87.00 | 111,587 | 9,708,069 | 5,050 | 116.6 K to 5.1 K (-95.67 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 1,162 | 0 | 116,637 | 117.8 K to 116.6 K (-0.99 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 12,251 | 0 | 117,799 | 130.1 K to 117.8 K (-9.42 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 417 | 0 | 130,050 | 129.6 K to 130.1 K (+0.32 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 25,000 | 0 | 129,633 | 154.6 K to 129.6 K (-16.17 %) |
Oct 06 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 447 | 0 | 154,633 | 154.2 K to 154.6 K (+0.29 %) |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 640 | 0 | 154,186 | 153.5 K to 154.2 K (+0.42 %) |
Jun 19 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
Apr 06 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 865 | 0 | 153,546 | 152.7 K to 153.5 K (+0.57 %) |
Jan 09 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 995 | 0 | 152,681 | 151.7 K to 152.7 K (+0.66 %) |
Oct 17 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 675 | 0 | 151,686 | 151 K to 151.7 K (+0.45 %) |
Jul 05 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 505 | 0 | 151,011 | 150.5 K to 151 K (+0.34 %) |
Jun 21 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | A | 42.40 | 12,000 | 508,800 | 12,000 | |
Apr 07 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 506 | 0 | 150,506 | 150 K to 150.5 K (+0.34 %) |
Jun 16 2015 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | A | 60.00 | 12,000 | 720,000 | 12,000 |
Page: 1